1. Home
  2. FBGL vs HCWB Comparison

FBGL vs HCWB Comparison

Compare FBGL & HCWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FBS Global Limited Ordinary Shares

FBGL

FBS Global Limited Ordinary Shares

N/A

Current Price

$0.44

Market Cap

5.3M

ML Signal

N/A

Logo HCW Biologics Inc.

HCWB

HCW Biologics Inc.

N/A

Current Price

$2.12

Market Cap

5.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FBGL
HCWB
Founded
1996
2018
Country
Singapore
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3M
5.0M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
FBGL
HCWB
Price
$0.44
$2.12
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$35.00
AVG Volume (30 Days)
183.5K
79.4K
Earning Date
05-15-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,099,750.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.34
$0.25
52 Week High
$1.40
$7.35

Technical Indicators

Market Signals
Indicator
FBGL
HCWB
Relative Strength Index (RSI) 44.07 34.34
Support Level $0.37 $1.68
Resistance Level $0.65 $2.15
Average True Range (ATR) 0.05 0.47
MACD -0.00 -0.15
Stochastic Oscillator 29.52 3.20

Price Performance

Historical Comparison
FBGL
HCWB

About FBGL FBS Global Limited Ordinary Shares

FBS Global Ltd is a green building contractor and an established interior fit-out specialist in institutional, residential, commercial, and industrial building projects. As a green contractor focused on environmentally sound practices, the company aims to bid tenders for green building projects, use green construction methods and green materials for construction projects, including design, supply, and installation of ceilings, partitions, timber deck, carpet, acoustic wall paneling, built-in furniture, as well as mechanical and electrical services of a building. The company's revenue is derived mainly from the construction contracts and sales of construction materials.

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.

Share on Social Networks: